DrugPatentWatch Database Preview
Drugs in Development Information for Orteronel
» See Plans and Pricing
What is the development status for investigational drug Orteronel?
Orteronel is an investigational drug.
There have been 17 clinical trials for Orteronel.
The most recent clinical trial was a Phase 3 trial, which was initiated on May 1st 2012.
The most common disease conditions in clinical trials are Prostatic Neoplasms, Breast Neoplasms, and Ovarian Neoplasms. The leading clinical trial sponsors are Millennium Pharmaceuticals, Inc., National Cancer Institute (NCI), and University of Wisconsin, Madison.
Summary for Orteronel
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 15 |
| WIPO Patent Applications | 273 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 3 (2012-05-01) |
| Vendors | 41 |
Recent Clinical Trials for Orteronel
| Title | Sponsor | Phase |
|---|---|---|
| AR-inhibitor Bicalutamide in Treating Patients With TNBC | Jiangsu Province Hospital of Traditional Chinese Medicine | Phase 2 |
| AR-inhibitor Bicalutamide in Treating Patients With TNBC | Nanning Second People's Hospital | Phase 2 |
| AR-inhibitor Bicalutamide in Treating Patients With TNBC | The First People's Hospital of Lianyungang | Phase 2 |
Clinical Trial Summary for Orteronel
Top disease conditions for Orteronel
Top clinical trial sponsors for Orteronel
US Patents for Orteronel
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
